|
US1844018A
(en)
*
|
1929-04-18 |
1932-02-09 |
Mead Res Engineering Company |
Method of preparing tanning substances
|
|
US3378587A
(en)
|
1963-03-14 |
1968-04-16 |
Du Pont |
3, 3'-diaminomethyl-1, 1'-biadamantane
|
|
NL127995C
(cg-RX-API-DMAC7.html)
|
1963-12-20 |
|
Geigy Ag J R |
|
|
US3341538A
(en)
|
1965-06-18 |
1967-09-12 |
Geigy Chem Corp |
Certain 2, 6-methano-3-benzazocines
|
|
DE2108954A1
(en)
|
1971-02-25 |
1972-09-07 |
Boehringer Sohn Ingelheim |
2-(furylmethyl)-6,7-benzomorphans - useful as cns active agents
|
|
DE1801556A1
(de)
|
1968-10-05 |
1970-05-21 |
Huels Chemische Werke Ag |
Verfahren zur Herstellung von substituierten Hexahydropyrimidinonen-(2)
|
|
US3817835A
(en)
*
|
1969-03-26 |
1974-06-18 |
Squibb & Sons Inc |
Process for the production of antimicrobial agents
|
|
GB1304175A
(cg-RX-API-DMAC7.html)
|
1969-03-31 |
1973-01-24 |
|
|
|
DE2105743C3
(de)
|
1971-02-08 |
1979-11-29 |
Boehringer Sohn Ingelheim |
2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
|
|
US3681349A
(en)
|
1970-03-05 |
1972-08-01 |
Morton Norwich Products Inc |
1-(substituted benzyl) tetrahydro-2-(1h) pyrimidones
|
|
US3824184A
(en)
*
|
1970-09-04 |
1974-07-16 |
Economics Lab |
Slime control in industrial waters
|
|
US4043927A
(en)
|
1972-03-07 |
1977-08-23 |
Sun Ventures, Inc. |
Friction or tractive drive containing ethers of adamantanes
|
|
DE2229695A1
(de)
|
1972-06-19 |
1974-01-31 |
Boehringer Sohn Ingelheim |
2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
|
|
DE2338369A1
(de)
|
1973-07-26 |
1975-02-13 |
Schering Ag |
Mikrobiologische hydroxylierung von 2,6-methano-3-benzazocinen
|
|
SU510999A3
(ru)
|
1973-10-27 |
1976-04-15 |
К.Х.Берингер Зон, (Фирма) |
Способ получени (метоксиметил-фурилметил)6,7-бензоморфанов илиморфинанов
|
|
US4009171A
(en)
|
1974-02-21 |
1977-02-22 |
Sterling Drug Inc. |
N-acylated-11-oxygenated-2,6-methano-3-benzazocine intermediates
|
|
DE2411382C3
(de)
|
1974-03-09 |
1979-09-06 |
C.H. Boehringer Sohn, 6507 Ingelheim |
2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
|
|
US4136162A
(en)
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
US4136145A
(en)
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
DE2437610A1
(de)
|
1974-08-05 |
1976-02-26 |
Boehringer Sohn Ingelheim |
Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
|
|
JPS5429599B2
(cg-RX-API-DMAC7.html)
*
|
1974-12-28 |
1979-09-25 |
|
|
|
SE7601543L
(sv)
*
|
1975-02-21 |
1976-08-23 |
Snam Progetti |
Forfarande for extrahering av fenoler och oligosackarider ur vegetabiliskt material
|
|
US4108857A
(en)
|
1975-08-18 |
1978-08-22 |
Sterling Drug Inc. |
Imidazolylmethyl methanobenzazocines
|
|
DE2828039A1
(de)
|
1978-06-26 |
1980-01-10 |
Boehringer Sohn Ingelheim |
2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
|
|
US4514334A
(en)
*
|
1979-05-31 |
1985-04-30 |
General Electric Company |
Polyphenolic compounds
|
|
FR2486523A1
(fr)
*
|
1980-07-11 |
1982-01-15 |
Rhone Poulenc Ind |
Procede de preparation de polyphenols comportant eventuellement un groupement aldehyde
|
|
US4829001A
(en)
*
|
1985-11-08 |
1989-05-09 |
Minnesota Mining And Manufacturing Company |
Enzymatic neutralization of hydrogen peroxide
|
|
US5296376A
(en)
*
|
1986-11-04 |
1994-03-22 |
Imperial Chemical Industries Plc |
DNA, constructs, cells and plants derived therefrom
|
|
US5231193A
(en)
*
|
1989-03-29 |
1993-07-27 |
Kikkoman Corporation |
Process for producing ellagic acid
|
|
US5393735A
(en)
|
1990-08-09 |
1995-02-28 |
Rohm And Haas Company |
Herbicidal glutarimides
|
|
CA2023492A1
(en)
|
1989-08-31 |
1991-03-01 |
Barry Clifford Lange |
Herbicidal glutarimides
|
|
US5098916A
(en)
|
1990-03-29 |
1992-03-24 |
G. D. Searle & Co. |
Propanobicyclic amine derivatives for cns disorders
|
|
EP0454444A1
(en)
|
1990-04-24 |
1991-10-30 |
Nissan Chemical Industries Ltd. |
Glutarimide derivatives and herbicides
|
|
US5215992A
(en)
|
1990-04-30 |
1993-06-01 |
G. D. Searle & Co. |
Ethanobicyclic amine derivatives for CNS disorders
|
|
US5089506A
(en)
|
1990-04-30 |
1992-02-18 |
G. D. Searle & Co. |
Ethanobicyclic amine derivatives for cns disorders
|
|
CA2049244A1
(en)
|
1990-08-16 |
1992-02-17 |
Steven H. Christiansen |
Process for absorption of sulfur compounds from fluids using heterocyclic compounds having at least one ring nitrogen atom
|
|
AU646519B2
(en)
|
1990-10-10 |
1994-02-24 |
Schering Corporation |
Pyridine and pyridine N-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof
|
|
US5389369A
(en)
*
|
1991-02-21 |
1995-02-14 |
Exoxemis, Inc. |
Halo peroxidase containing compositions for killing yeast and sporular microorganisms
|
|
US5756090A
(en)
*
|
1991-02-21 |
1998-05-26 |
Eoe, Inc. |
Oxygen activatable formulations for disinfection or sterilization
|
|
US5208010A
(en)
*
|
1991-06-17 |
1993-05-04 |
Dental Concepts Inc. |
Tooth whitening dentifrice
|
|
US5610294A
(en)
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
|
FI935920A7
(fi)
|
1992-04-30 |
1993-12-29 |
Taiho Pharmaceutical Co Ltd |
Oksatsolidiinijohdannaiset ja niiden farmaseuttisesti hyväksyttävät suolat
|
|
GB9225377D0
(en)
|
1992-12-04 |
1993-01-27 |
Ici Plc |
Herbicides
|
|
US5328706A
(en)
*
|
1993-04-29 |
1994-07-12 |
Endico Felix W |
Food manufacturing process utilizing hydrogen peroxide for microbial control
|
|
US6068862A
(en)
*
|
1993-06-30 |
2000-05-30 |
Taiyo Kagaku Co., Ltd. |
Tea-derived feed additive and animal feed containing the same
|
|
TW280812B
(cg-RX-API-DMAC7.html)
|
1993-07-02 |
1996-07-11 |
Bayer Ag |
|
|
EP0640594A1
(en)
|
1993-08-23 |
1995-03-01 |
Fujirebio Inc. |
Hydantoin derivative as metalloprotease inhibitor
|
|
DE19500118A1
(de)
|
1994-05-18 |
1995-11-23 |
Bayer Ag |
Substituierte Diazacyclohexandi(thi)one
|
|
US5614501A
(en)
*
|
1994-07-21 |
1997-03-25 |
The University Of Montana |
Compositions and methods for animal husbandry and for treating gastrointestinal disorders
|
|
FR2729954B1
(fr)
|
1995-01-30 |
1997-08-01 |
Sanofi Sa |
Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
|
|
US5780466A
(en)
|
1995-01-30 |
1998-07-14 |
Sanofi |
Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
|
|
GB9510459D0
(en)
|
1995-05-24 |
1995-07-19 |
Zeneca Ltd |
Bicyclic amines
|
|
US5776959A
(en)
|
1995-06-05 |
1998-07-07 |
Washington University |
Anticonvulsant and anxiolytic lactam and thiolactam derivatives
|
|
GB9517622D0
(en)
|
1995-08-29 |
1995-11-01 |
Univ Edinburgh |
Regulation of intracellular glucocorticoid concentrations
|
|
US6063428A
(en)
*
|
1996-02-26 |
2000-05-16 |
The Procter & Gamble Company |
Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color
|
|
JP3320307B2
(ja)
*
|
1996-06-06 |
2002-09-03 |
株式会社エス・ディー・エス バイオテック |
フェノール性化合物等の高分子化方法及びその利用
|
|
JP3192662B2
(ja)
|
1996-07-31 |
2001-07-30 |
日研化学株式会社 |
６―フェニルテトラヒドロ―１，３―オキサジン―２―オン誘導体及びそれを含む医薬組成物
|
|
US6794390B2
(en)
|
1996-08-02 |
2004-09-21 |
Cv Therapeutics, Inc. |
Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha
|
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
|
EP2255661A3
(en)
*
|
1996-10-16 |
2010-12-22 |
Napo Pharmaceuticals, Inc. |
Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
|
|
GB9623944D0
(en)
|
1996-11-15 |
1997-01-08 |
Zeneca Ltd |
Bicyclic amine derivatives
|
|
ES2163813T3
(es)
*
|
1996-11-25 |
2002-02-01 |
Unilever Nv |
Proceso de oxidacion enzimatica.
|
|
US6159990A
(en)
|
1997-06-18 |
2000-12-12 |
Synaptic Pharmaceutical Corporation |
Oxazolidinones as α1A receptor antagonists
|
|
JP4137224B2
(ja)
*
|
1998-03-31 |
2008-08-20 |
天野エンザイム株式会社 |
酵素による蛋白質の架橋法
|
|
US5936124A
(en)
|
1998-06-22 |
1999-08-10 |
Sepacor Inc. |
Fluoxetine process from benzoylpropionic acid
|
|
DE19918725A1
(de)
|
1999-04-24 |
2000-10-26 |
Bayer Ag |
Substituierte N-Cyano-sulfonsäureanilide
|
|
US7504251B2
(en)
*
|
1999-06-03 |
2009-03-17 |
Biobalance Llc |
Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
|
|
DE19929348A1
(de)
|
1999-06-26 |
2000-12-28 |
Bayer Ag |
Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten
|
|
GB9918028D0
(en)
*
|
1999-07-30 |
1999-09-29 |
Unilever Plc |
Skin care composition
|
|
US7256005B2
(en)
|
1999-08-10 |
2007-08-14 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
|
|
US6348472B1
(en)
|
1999-08-26 |
2002-02-19 |
Bristol-Myers Squibb Company |
NPY antagonists: spiroisoquinolinone derivatives
|
|
EP1237874B1
(en)
*
|
1999-12-17 |
2006-02-22 |
Schering Corporation |
Selective neurokinin antagonists
|
|
US6436928B1
(en)
|
1999-12-17 |
2002-08-20 |
Schering Corporation |
Selective neurokinin antagonists
|
|
GB0003397D0
(en)
|
2000-02-14 |
2000-04-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
DE10034623A1
(de)
|
2000-07-17 |
2002-01-31 |
Bayer Ag |
Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren
|
|
DE10034803A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Sulfonsäureanilide
|
|
DE10034800A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Benzostickstoffheterocyclen
|
|
DE10035928A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
DE10035927A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
DE10035908A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
US6559163B2
(en)
|
2000-08-16 |
2003-05-06 |
Neurogen Corporation |
2,4-substituted quinoline derivatives
|
|
CA2422055A1
(en)
|
2000-09-11 |
2002-03-21 |
Sepracor, Inc. |
Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
|
|
US7294637B2
(en)
|
2000-09-11 |
2007-11-13 |
Sepracor, Inc. |
Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
|
|
US20020034553A1
(en)
*
|
2000-09-19 |
2002-03-21 |
Janice Zayas |
Skin healing, conditioning and enhancing lotion
|
|
US6841671B2
(en)
|
2000-10-26 |
2005-01-11 |
Pfizer Inc. |
Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
|
|
US20030143668A1
(en)
|
2001-06-18 |
2003-07-31 |
National Institute Of Advanced Industrial |
Guanosine triphosphate-binding protein coupled receptors
|
|
JP3873115B2
(ja)
|
2001-09-25 |
2007-01-24 |
独立行政法人産業技術総合研究所 |
環状ウレタン製造方法
|
|
PE20030477A1
(es)
|
2001-10-15 |
2003-06-06 |
Schering Corp |
ANTAGONISTAS DEL RECEPTOR DE ADENOSINA A2a
|
|
IL161940A0
(en)
|
2001-11-22 |
2005-11-20 |
Ono Pharmaceutical Co |
Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
|
|
EP1501834B1
(en)
|
2002-04-26 |
2005-09-07 |
Pfizer Products Inc. |
Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
|
|
JP2005529895A
(ja)
|
2002-04-26 |
2005-10-06 |
ファイザー・プロダクツ・インク |
Ｎ置換へテロアリールオキシ−アリール−スピロ−ピリミジン−２，４，６−トリオンメタロプロテイナーゼ阻害剤
|
|
DE60335359D1
(de)
|
2002-04-30 |
2011-01-27 |
Kudos Pharm Ltd |
Phthalazinonderivate
|
|
AU2003234621A1
(en)
|
2002-05-17 |
2003-12-02 |
Jenken Biosciences, Inc. |
Opioid and opioid-like compounds and uses thereof
|
|
ATE358482T1
(de)
|
2002-07-03 |
2007-04-15 |
Schering Corp |
1-amido-4-phenyl-4-benzyloxymethyl-piperidin derivative und verwandte verbindungen als neurokinin-1 (nk-1) antagonsisten zur behandlung von erbrechen, depressionen, angstzustände und husten
|
|
AU2003249812A1
(en)
|
2002-07-18 |
2004-02-09 |
Queen's University At Kingston |
Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents
|
|
GB0218630D0
(en)
|
2002-08-10 |
2002-09-18 |
Tanabe Seiyaku Co |
Novel compounds
|
|
TWI347946B
(en)
|
2002-10-11 |
2011-09-01 |
Otsuka Pharma Co Ltd |
2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
|
|
WO2004046137A1
(en)
|
2002-11-21 |
2004-06-03 |
Vicore Pharma Ab |
New tricyclic angiotensin ii agonists
|
|
AU2003293082A1
(en)
*
|
2002-11-27 |
2004-06-23 |
Tufts University |
Antioxidant-functionalized polymers
|
|
GB0228410D0
(en)
|
2002-12-05 |
2003-01-08 |
Glaxo Group Ltd |
Novel Compounds
|
|
US7208487B2
(en)
|
2002-12-13 |
2007-04-24 |
Cytokinetics, Incorporated |
Compounds, compositions and methods
|
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
AU2004226452B2
(en)
|
2003-03-26 |
2008-07-24 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
|
|
US7700583B2
(en)
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
ATE482747T1
(de)
|
2003-04-11 |
2010-10-15 |
High Point Pharmaceuticals Llc |
Neue amide derivate und deren pharmazeutische verwendungen
|
|
DE10358004A1
(de)
|
2003-12-11 |
2005-07-14 |
Abbott Gmbh & Co. Kg |
Ketolactam-Verbindungen und ihre Verwendung
|
|
US7186844B2
(en)
|
2004-01-13 |
2007-03-06 |
Mitsubishi Gas Chemical Co., Inc. |
Method for producing cyclic carbamate ester
|
|
JP4324669B2
(ja)
|
2004-01-21 |
2009-09-02 |
独立行政法人産業技術総合研究所 |
環状ウレタンの製造方法
|
|
JP2005239670A
(ja)
|
2004-02-27 |
2005-09-08 |
Ono Pharmaceut Co Ltd |
含窒素複素環化合物およびその医薬用途
|
|
WO2005086700A2
(en)
|
2004-03-09 |
2005-09-22 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
|
US8519158B2
(en)
|
2004-03-12 |
2013-08-27 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
|
JP2005272321A
(ja)
|
2004-03-23 |
2005-10-06 |
Ono Pharmaceut Co Ltd |
含窒素複素環化合物およびその医薬用途
|
|
CA2560826C
(en)
*
|
2004-03-23 |
2014-05-13 |
Lifeline Nutraceuticals Corporation |
Antioxidant-promoting herbal extract compositions for alleviating oxidative stress in a mammal
|
|
GB0411404D0
(en)
|
2004-05-21 |
2004-06-23 |
Glaxo Group Ltd |
Novel compounds
|
|
AR049344A1
(es)
|
2004-05-24 |
2006-07-19 |
Amgen Inc |
Inhibidores de la 11-beta-hidroxi esteroide deshidrogenasa de tipo 1
|
|
EP1758582A4
(en)
|
2004-06-24 |
2008-01-09 |
Incyte Corp |
AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICAL PRODUCTS
|
|
GB0414438D0
(en)
|
2004-06-28 |
2004-07-28 |
Syngenta Participations Ag |
Chemical compounds
|
|
DOP2005000123A
(es)
|
2004-07-02 |
2011-07-15 |
Merck Sharp & Dohme |
Inhibidores de cetp
|
|
EP1621536A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
EP1621539A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
EP1621535A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
AR050365A1
(es)
|
2004-08-02 |
2006-10-18 |
Osi Pharm Inc |
Compuestos inhibidores de multi- quinasa pirrolopirimidina aril- amino sustituidos.
|
|
JP2008510823A
(ja)
|
2004-08-23 |
2008-04-10 |
メルク エンド カムパニー インコーポレーテッド |
Ａｋｔ活性阻害剤
|
|
EP1796657B1
(en)
|
2004-08-30 |
2009-12-23 |
Janssen Pharmaceutica N.V. |
N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
CN101056862B
(zh)
|
2004-09-10 |
2013-03-13 |
詹森药业有限公司 |
作为选择性雄激素受体调节剂（sarms）的咪唑烷-2-酮衍生物
|
|
GEP20125565B
(en)
|
2004-11-10 |
2012-07-10 |
Incyte Corp |
Lactam compounds and their pharmaceutical use
|
|
US20060167044A1
(en)
|
2004-12-20 |
2006-07-27 |
Arnaiz Damian O |
Piperidine derivatives and their use as anti-inflammatory agents
|
|
KR20070090915A
(ko)
|
2004-12-23 |
2007-09-06 |
키에시 파르마슈티시 엣스. 피. 에이. |
항 무스카린성 활성을 가진 아졸유도체
|
|
CA2590961C
(en)
|
2004-12-28 |
2013-11-26 |
Exelixis, Inc. |
[1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
|
|
AU2006206246A1
(en)
|
2005-01-19 |
2006-07-27 |
Neurogen Corporation |
Heteroaryl substituted piperazinyl-pyridine analogues
|
|
US7417045B2
(en)
|
2005-02-16 |
2008-08-26 |
Schering Corporation |
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
|
|
EP1848710B1
(en)
|
2005-02-16 |
2013-10-16 |
Merck Sharp & Dohme Corp. |
Heterocyclic substituted piperazines with cxcr3 antagonist activity
|
|
WO2006088921A2
(en)
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
|
|
CN101213185A
(zh)
|
2005-02-16 |
2008-07-02 |
先灵公司 |
具有cxcr3拮抗活性的吡啶基和苯基取代的哌嗪-哌啶
|
|
EP1858895B1
(en)
|
2005-02-16 |
2012-06-20 |
Schering Corporation |
Piperazine-piperidines with cxcr3 antagonist activity
|
|
MX2007009948A
(es)
|
2005-02-16 |
2007-09-26 |
Schering Corp |
Pierazin-piperidinas sustituidas con piridilo y fenilo conectados por aminos con actividad antagonista de cxcr3.
|
|
CN101111485B
(zh)
|
2005-02-24 |
2010-10-27 |
日本农药株式会社 |
新颖的卤代烷基磺酰苯胺衍生物、除草剂及其使用方法
|
|
US20090264650A1
(en)
|
2005-03-31 |
2009-10-22 |
Nobuo Cho |
Prophylactic/Therapeutic Agent for Diabetes
|
|
KR101284573B1
(ko)
|
2005-04-12 |
2013-07-11 |
바이코어 파마 아베 |
신규한 트리시클릭 안지오텐신 ⅱ 아고니스트
|
|
US20080311139A1
(en)
*
|
2005-05-27 |
2008-12-18 |
University Of Central Florida Research Foundation, Inc. |
Plant Produced Vaccine for Amebiasis
|
|
WO2007008529A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc |
Celullar cholesterol absorption modifiers
|
|
MX2008002214A
(es)
|
2005-08-16 |
2008-11-27 |
Genzyme Corp |
Compuestos de unión del receptor de quimiocina.
|
|
ATE546445T1
(de)
|
2005-10-11 |
2012-03-15 |
Schering Corp |
Substituierte heterocyclische verbindungen mit cxcr3-antagonistischer wirkung
|
|
CA2627234A1
(en)
|
2005-10-27 |
2007-05-03 |
Ucb Pharma, S.A. |
Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
|
|
JP2007140188A
(ja)
|
2005-11-18 |
2007-06-07 |
Fujifilm Corp |
ポジ型感光性組成物及びそれを用いたパターン形成方法
|
|
MX2008006530A
(es)
|
2005-11-22 |
2008-09-25 |
Amgen Inc |
Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1.
|
|
BRPI0619446A2
(pt)
|
2005-12-05 |
2011-10-04 |
Incyte Corp |
compostos de lactama, suas composições e método de modulação da atividade de 11bhsd1
|
|
WO2007079331A2
(en)
*
|
2005-12-13 |
2007-07-12 |
Richard Paul Bonfiglio |
Antibacterial oral rinse formulation for preventing coronary artery disease
|
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
|
WO2007076055A2
(en)
|
2005-12-22 |
2007-07-05 |
Entremed, Inc. |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
DE102005062990A1
(de)
|
2005-12-28 |
2007-07-05 |
Grünenthal GmbH |
Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
|
|
NZ568904A
(en)
|
2005-12-30 |
2011-05-27 |
Merck Sharp & Dohme |
1,3-oxazolidin-2-one derivatives useful as CETP inhibitors
|
|
AU2006335109B2
(en)
|
2005-12-30 |
2011-04-07 |
Merck Sharp & Dohme Corp. |
Cholesteryl ester transfer protein inhibitors
|
|
JP5229567B2
(ja)
|
2005-12-30 |
2013-07-03 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Ｃｅｔｐ阻害剤
|
|
AU2006335110B2
(en)
|
2005-12-30 |
2011-04-14 |
Merck Sharp & Dohme Corp. |
CETP inhibitors
|
|
US7998959B2
(en)
|
2006-01-12 |
2011-08-16 |
Incyte Corporation |
Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
|
WO2007090096A2
(en)
*
|
2006-01-27 |
2007-08-09 |
Rdx Technologies, Inc. |
Electrochemical methods for redox control to preserve, stabilize and activate compounds
|
|
CA3044828A1
(en)
|
2006-02-27 |
2007-09-07 |
Ascensia Diabetes Care Holdings Ag |
Temperature adjusted analyte determination for biosensor systems
|
|
TW200808807A
(en)
|
2006-03-02 |
2008-02-16 |
Incyte Corp |
Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
|
WO2007109456A2
(en)
|
2006-03-16 |
2007-09-27 |
Pharmacopeia, Inc. |
Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists
|
|
JP2007254409A
(ja)
|
2006-03-24 |
2007-10-04 |
Taisho Pharmaceut Co Ltd |
イミダゾリジノン誘導体
|
|
US7435833B2
(en)
|
2006-04-07 |
2008-10-14 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
CN101426769A
(zh)
|
2006-04-20 |
2009-05-06 |
杜邦公司 |
五元杂环无脊椎害虫防治剂
|
|
CA2648019C
(en)
|
2006-04-25 |
2014-04-01 |
Eli Lilly And Company |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
US8178005B2
(en)
|
2006-06-20 |
2012-05-15 |
Chemtura Corporation |
Liquid phosphite compositions having different alkyl groups
|
|
TW200811170A
(en)
|
2006-06-27 |
2008-03-01 |
Sanofi Aventis |
Urea derivatives of tropane, their preparation and their therapeutic application
|
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
WO2008012622A2
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
US7649007B2
(en)
|
2006-08-15 |
2010-01-19 |
Wyeth Llc |
Oxazolidine derivatives as PR modulators
|
|
US7538107B2
(en)
|
2006-08-15 |
2009-05-26 |
Wyeth |
Oxazinan-2-one derivatives useful as PR modulators
|
|
US7618989B2
(en)
|
2006-08-15 |
2009-11-17 |
Wyeth |
Tricyclic oxazolidone derivatives useful as PR modulators
|
|
CA2661503A1
(en)
|
2006-08-25 |
2008-02-28 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11.beta. -hydroxysteroid dehydrogenase type 1
|
|
CA2663280A1
(en)
|
2006-09-14 |
2008-03-20 |
Neuromed Pharmaceuticals Ltd. |
Diaryl piperidine compounds as calcium channel blockers
|
|
WO2008036715A1
(en)
|
2006-09-22 |
2008-03-27 |
Novartis Ag |
Heterocyclic organic compounds
|
|
DE102007005799B4
(de)
|
2006-10-18 |
2018-01-25 |
Heinz-Jürgen Mühlen |
Verfahren zur Erzeugung eines wasserstoffreichen Produktgases
|
|
TW200829171A
(en)
|
2006-11-17 |
2008-07-16 |
Nihon Nohyaku Co Ltd |
Haloalkyl sulfonanilide derivatives or salts thereof, herbicide using it as effective constituent and use-method thereof
|
|
EP1935420A1
(en)
|
2006-12-21 |
2008-06-25 |
Merck Sante |
2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
|
|
US8835426B2
(en)
|
2007-02-26 |
2014-09-16 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
JP2010522174A
(ja)
|
2007-03-23 |
2010-07-01 |
シェーリング コーポレイション |
Ｈｃｖｎｓ３−プロテアーゼ阻害剤としてのヒドラジド−ペプチド
|
|
AU2008233930A1
(en)
|
2007-03-29 |
2008-10-09 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
ATE554078T1
(de)
|
2007-07-26 |
2012-05-15 |
Vitae Pharmaceuticals Inc |
Synthese von 11-beta-hydroxysteroid-dehydrogenase-1-hemmern
|
|
WO2009020140A1
(ja)
|
2007-08-06 |
2009-02-12 |
Dainippon Sumitomo Pharma Co., Ltd. |
アダマンチルウレア誘導体
|
|
PL2187736T3
(pl)
*
|
2007-08-16 |
2016-01-29 |
Univ Chicago |
Odporność na patogeny roślin
|
|
AR069207A1
(es)
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
|
WO2009063061A2
(en)
|
2007-11-16 |
2009-05-22 |
Boehringer Ingelheim International Gmbh |
Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
|
|
WO2009075835A1
(en)
|
2007-12-11 |
2009-06-18 |
Vitae Pharmaceutical, Inc |
CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
|
|
KR101460359B1
(ko)
|
2007-12-13 |
2014-11-10 |
삼성전자주식회사 |
이동통신 시스템에서의 핸드오버 방법 및 장치
|
|
TW200934490A
(en)
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
|
JP5734666B2
(ja)
|
2008-02-11 |
2015-06-17 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤
|
|
US20110028445A1
(en)
|
2008-02-12 |
2011-02-03 |
Boehringer Ingelheim International Gmbh |
Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
|
|
EP2254872A2
(en)
|
2008-02-15 |
2010-12-01 |
Vitae Pharmaceuticals, Inc. |
Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
JP5108557B2
(ja)
|
2008-02-27 |
2012-12-26 |
東京エレクトロン株式会社 |
ロードロック装置および基板冷却方法
|
|
EP2265588B1
(en)
|
2008-02-27 |
2013-06-26 |
Vitae Pharmaceuticals, Inc. |
INHIBITORS OF 11ß -HYDROXYSTEROID DEHYDROGENASE TYPE 1
|
|
JP5538356B2
(ja)
|
2008-03-18 |
2014-07-02 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
|
|
TW200944526A
(en)
|
2008-04-22 |
2009-11-01 |
Vitae Pharmaceuticals Inc |
Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
US8592410B2
(en)
|
2008-05-01 |
2013-11-26 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1
|
|
CA2723032A1
(en)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
CL2009001058A1
(es)
|
2008-05-01 |
2010-09-10 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
|
|
AU2009241727B2
(en)
|
2008-05-01 |
2013-05-02 |
Vitae Pharmaceuticals, Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8765780B2
(en)
|
2008-05-13 |
2014-07-01 |
Boehringer Ingelheim International Gmbh |
Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
|
|
US20110224242A1
(en)
|
2008-07-23 |
2011-09-15 |
Bioalliance Pharma |
Styrlyquinolines, their process of preparation and their therapeutic uses
|
|
EP2318355B1
(en)
|
2008-07-25 |
2018-09-12 |
Boehringer Ingelheim International GmbH |
1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
|
|
JP5379160B2
(ja)
|
2008-07-25 |
2013-12-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
|
|
CA2729998A1
(en)
|
2008-07-25 |
2010-01-28 |
Boehringer Ingelheim International Gmbh |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
CA2729993A1
(en)
|
2008-07-25 |
2010-01-28 |
Boehringer Ingelheim International Gmbh |
Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
CA2735204C
(en)
|
2008-08-25 |
2017-06-20 |
Boehringer Ingelheim International Gmbh |
Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
|
|
WO2010046445A2
(en)
|
2008-10-23 |
2010-04-29 |
Boehringer Ingelheim International Gmbh |
Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
|
|
EP2393813B1
(en)
|
2009-02-04 |
2013-07-31 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11 ß-hydroxysteroid dehydrogenase 1 useful for the treatment of diseases related to elevated level of cortisol
|
|
CA2744946A1
(en)
|
2009-02-04 |
2010-08-12 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
|
|
WO2010104830A1
(en)
|
2009-03-09 |
2010-09-16 |
Bristol-Myers Squibb Company |
Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
|
|
GEP20156309B
(en)
|
2009-04-30 |
2015-07-10 |
Vitae Pharmaceuticals Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
MA33216B1
(fr)
|
2009-04-30 |
2012-04-02 |
Boehringer Ingelheim Int |
Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
|
|
WO2010139673A1
(en)
|
2009-06-02 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
AR076936A1
(es)
|
2009-06-02 |
2011-07-20 |
Vitae Pharmaceuticals Inc |
Inhibidores de carbamato y urea de la 11 beta hidroxiesteroide deshidrogenasa 1
|
|
EP2440537A1
(en)
|
2009-06-11 |
2012-04-18 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
|
|
JP5749263B2
(ja)
|
2009-07-01 |
2015-07-15 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
|
|
AU2010292116A1
(en)
|
2009-09-11 |
2012-05-03 |
Cylene Pharmaceuticals Inc. |
Pharmaceutically useful heterocycle-substituted lactams
|
|
US8552212B2
(en)
|
2009-11-05 |
2013-10-08 |
Boehringer Ingelheim International Gmbh |
Chiral phosphorus ligands
|
|
UY33001A
(es)
|
2009-11-06 |
2011-05-31 |
Boehringer Ingelheim Int |
Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina
|
|
JP5860042B2
(ja)
|
2010-06-16 |
2016-02-16 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
置換５、６及び７員複素環、そのような化合物を含有する医薬及びそれらの使用
|
|
JP5813106B2
(ja)
|
2010-06-25 |
2015-11-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
代謝障害の処置のための１１−β−ＨＳＤ１のインヒビターとしてのアザスピロヘキサノン
|
|
CA2813671A1
(en)
|
2010-11-02 |
2012-05-10 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical combinations for the treatment of metabolic disorders
|